Clorox (CLX) Financial Analysis & Valuation | Quarter Chart
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primar... more
The Clorox Company manufactures and markets consumer and professional products worldwide. It operate... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $10.05B | Exchange | NYSE |
| Sector | Consumer Defensive | Industry | Household & Personal Products |
| Country | US | CEO | Linda J. Rendle |
| IPO Date | 1983-03-21 | CAGR | 4.65% |
| Employees | 9,200 | Website | www.thecloroxcompany.com |
| Div. Yield | 30.87% | Payout Ratio | 103% |
| Buy Back Yield | 16.94% | Total Yield | 47.81% |
CLX chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $14.40B | P/E | 15 | Forward P/E | 13.27 | PEG | -0.35 |
| P/S | 0.29 | P/B | 21.89 | P/CF | 3.42 | P/FCF | 5.15 |
| Sales | $6.72B | Sales 1Y | -5.41% | Sales 3Y | -9.05% | Sales 5Y | -8.46% |
| EPS | $5.54 | EPS 1Y | -26.11% | EPS 3Y | 294.26% | EPS 5Y | -13.18% |
| Sales QoQ | 16.65% | EPS QoQ | -13.64% | Sales QoQ Avg | 1.36% | EPS QoQ Avg | 7.11% |
| Gross Margin | 42.32% | Operating Margin | 24.73% | Profit Margin | 8.74% | ROCE | 33.1% |
| ROA | 8% | ROE | -1894% | Altman Z Score | 1.92 | Piotroski Score | 4 |
| Current Ratio | 0.66 | Quick Ratio | 0.38 | Cash Ratio | 0.05 | Op. CF Ratio | -0.04 |
| Debt/Equity | 61.49 | Debt/Assets | 0.71 | Lt Debt/Equity | 48.3 | Lt Debt/Cap. | 0.98 |
| Intrst Cov. | 12.78 | Inventory Turnover | 4.99 | Asset Turnover | 0.86 | Receivables Turnover | 8.5 |
| Enterprise Value | $14.40B | P/E Ratio | 15 |
| Forward P/E | 13.27 | PEG Ratio | -0.35 |
| P/S Ratio | 0.29 | P/B Ratio | 21.89 |
| P/CF Ratio | 3.42 | P/FCF Ratio | 5.15 |
| EPS | $5.54 | EPS Growth 1Y | -26.11% |
| EPS Growth 3Y | 294.26% | EPS Growth 5Y | -13.18% |
| Revenue Growth 1Y | -5.41% | Gross Margin | 42.32% |
| Operating Margin | 24.73% | Profit Margin | 8.74% |
| ROE | -1894% | ROA | 8% |
| ROCE | 33.1% | Current Ratio | 0.66 |
| Quick Ratio | 0.38 | Cash Ratio | 0.05 |
| Debt/Equity | 61.49 | Interest Coverage | 12.78 |
| Altman Z Score | 1.92 | Piotroski Score | 4 |
Clorox (CLX) valuation & financials
Clorox (CLX) has a market capitalization of $10.05B and trades at a price-to-earnings ratio of 15.0. It operates in the Consumer Defensive sector (Household & Personal Products).
Clorox's revenue grew -5.4% over the last year.
Clorox's next earnings report is scheduled for November 3, 2026 after market close (provider scheduled date); analysts estimate EPS of $1.11. Check the earnings calendar to see all companies reporting this week.
Compare with other Consumer Defensive companies: Walmart (WMT) · Costco (COST) · Coca-Cola (KO) · Procter & Gamble (PG) · Philip Morris (PM) · Nestlé (NESN.SW)